ALT
Price
$4.00
Change
+$0.08 (+2.04%)
Updated
Sep 26 closing price
Capitalization
353.03M
44 days until earnings call
VERA
Price
$28.20
Change
+$1.24 (+4.60%)
Updated
Sep 26 closing price
Capitalization
1.8B
38 days until earnings call
Interact to see
Advertisement

ALT vs VERA

Header iconALT vs VERA Comparison
Open Charts ALT vs VERABanner chart's image
Altimmune
Price$4.00
Change+$0.08 (+2.04%)
Volume$2.5M
Capitalization353.03M
Vera Therapeutics
Price$28.20
Change+$1.24 (+4.60%)
Volume$1.6M
Capitalization1.8B
ALT vs VERA Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. VERA commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ALT: $4.00 vs. VERA: $28.20)
Brand notoriety: ALT and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 92% vs. VERA: 97%
Market capitalization -- ALT: $353.03M vs. VERA: $1.8B
ALT [@Biotechnology] is valued at $353.03M. VERA’s [@Biotechnology] market capitalization is $1.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 6 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • ALT’s TA Score: 6 bullish, 2 bearish.
  • VERA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ALT is a better buy in the short-term than VERA.

Price Growth

ALT (@Biotechnology) experienced а +5.82% price change this week, while VERA (@Biotechnology) price change was +10.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

ALT is expected to report earnings on Nov 11, 2025.

VERA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.8B) has a higher market cap than ALT($353M). VERA YTD gains are higher at: -33.318 vs. ALT (-44.522). ALT has higher annual earnings (EBITDA): -88.03M vs. VERA (-210.52M). VERA has more cash in the bank: 557M vs. ALT (183M). ALT has less debt than VERA: ALT (15.8M) vs VERA (77.6M). ALT has higher revenues than VERA: ALT (20K) vs VERA (0).
ALTVERAALT / VERA
Capitalization353M1.8B20%
EBITDA-88.03M-210.52M42%
Gain YTD-44.522-33.318134%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash183M557M33%
Total Debt15.8M77.6M20%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTVERA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITMSF2.180.01
+0.46%
Intermap Technologies Corp.
NGKSF29.92N/A
N/A
NITERRA CO LTD.
RUSMF28.70-0.20
-0.69%
Russel Metals Inc.
ZFSVF699.00-16.00
-2.24%
Zurich Insurance Group Ltd
NPRFF0.12-0.01
-9.84%
NEPRA FOODS INC.

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+2.04%
ACHV - ALT
51%
Loosely correlated
+1.35%
RVPH - ALT
51%
Loosely correlated
N/A
INDP - ALT
45%
Loosely correlated
+6.40%
VERA - ALT
39%
Loosely correlated
+4.60%
KROS - ALT
38%
Loosely correlated
+1.58%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+4.60%
KYMR - VERA
58%
Loosely correlated
+4.68%
LYRA - VERA
53%
Loosely correlated
+1.73%
OPORF - VERA
50%
Loosely correlated
N/A
MLTX - VERA
40%
Loosely correlated
+9.95%
VYGR - VERA
39%
Loosely correlated
+10.51%
More